Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes

DOI10.1016/J.JTBI.2008.07.002zbMATH Open1405.92125OpenAlexW2084697628WikidataQ81700450 ScholiaQ81700450MaRDI QIDQ1623948FDOQ1623948

Sophie Chareyron, Mazen Alamir

Publication date: 15 November 2018

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2008.07.002

zbMATH Keywords

model adaptationnonlinear predictive controlmixed cancer therapyreactive cancer treatment

Mathematics Subject Classification ID

Medical applications (general) (92C50) Sensitivity (robustness) (93B35) Applications of optimal control and differential games (49N90) Feedback control (93B52)

Cites Work

• Title not available (Why is that?)
• Title not available (Why is that?)
• ANALYSIS OF A CELL-CYCLE SPECIFIC MODEL FOR CANCER CHEMOTHERAPY
• Modeling immunotherapy of the tumor -- immune interaction
• A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
• A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
• Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
• Application of optimal control theory to analysis of cancer chemotherapy regimens
• MATHEMATICAL TOPICS ON THE MODELLING COMPLEX MULTICELLULAR SYSTEMS AND TUMOR IMMUNE CELLS COMPETITION
• Optimal Control Applied to Cell-Cycle-Specific Cancer Chemotherapy
• Stabilization of nonlinear systems using receding-horizon control schemes. A parametrized approach for fast systems.

Cited In (14)

• The effect of finite duration inputs on the dynamics of a system: Proposing a new approach for cancer treatment
• Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method
• Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control
• In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach
• Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function
• Learning-based sensitivity analysis and feedback design for drug delivery of mixed therapy of cancer in the presence of high model uncertainties
• Robust feedback design for combined therapy of cancer
• Iterative method for estimating the robust domains of attraction of non-linear systems: application to cancer chemotherapy model with parametric uncertainties
• Optimal chemotherapy in cancer treatment: state dependent Riccati equation control and extended Kalman filter
• On probabilistic certification of combined cancer therapies using strongly uncertain models
• Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
• Proportional observer design based on \(\mathcal{D}\)-stability and Finsler's lemma for Takagi-Sugeno systems
• Targeting the quiescent cells in cancer chemotherapy treatment: is it enough?
• Corrigendum to ``A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy

This page was built for publication: Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1623948)